StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$8.74−0.74 (-7.81%)

Close on Nov 18, 2026Market cap $349.60MP/E –Yield –

Adlai Nortye revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $5.00M, up 0.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.00M0.0%
FY2023Dec 31, 2023$5.00M-89.1%
FY2021Dec 31, 2021$45.73M–

More Adlai Nortye figures

See a number that looks wrong?